Embryonic Ploidy Status in the Oncofertility Population



Status:Enrolling by invitation
Conditions:Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:18 - 45
Updated:4/6/2019
Start Date:December 1, 2017
End Date:September 20, 2023

Use our guide to learn which trials are right for you!

looking at aneuploidy rates in embryos from patients who are going to or have undergone
treatment for a malignancy with gonadotoxic treatment.

The study involves oncofertility patients--individuals who are undergoing or have undergone
therapy for a malignancy--who are interested in pursuing or preserving fertility. In
particular, it investigates chromosomal abnormalities or aneuploidy in the embryos of those
individuals as compared to the general infertility population. Embryonic aneuploidy is
largely due to reproductive senescence. As such the investigators will discuss oncofertility
prevalence and treatment as well as reproductive senescence and assessment of embryonic
aneuploidy. The study will seek to determine if there are changes in embryonic aneuploidy
rates in oncofertility patients that differ from simple age related risks.

Inclusion Criteria:

1.Present or past oncologic diagnosis requiring potentially gonadotoxic treatment

Exclusion Criteria:

1. Oocyte banking

2. Use of oocyte donation

3. Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation

4. Single gene disorder requiring more detailed embryo genetic analysis
We found this trial at
1
site
Basking Ridge, New Jersey 07960
?
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials